As the life sciences industry faces increasing complexities with commercialization and patient care, generative AI emerges as a powerful ally for market success. And while it has been rapidly expanding its use cases within the life sciences industry, it’s initial focus has been primarily on efficiency gains and productivity improvements.

However, its true power lies beyond these applications, with the potential to reshape experiences and explore new frontiers. The shift from viewing AI as a mere productivity tool to recognizing it as a transformative force marks a significant inflection point for the industry. As testament to its transformative potential, HFS Research and Indegene found that 70% of global life sciences enterprise executives are actively investigating or working with GenAI as an enabling technology.